MT-ND2

NADH-ubiquinone oxidoreductase chain 2 · P03891 · MT-ND2 on Sugi Atlas →

3,019 patent compounds predicted against MT-ND2, 1,820 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Auraptene Auraptene (SCHEMBL2535029) 1.00 5/20
Auraptene Auraptene (SCHEMBL2535034) 1.00 5/20
SCHEMBL8491443 SCHEMBL8491443 0.56 4/20
SCHEMBL8489900 SCHEMBL8489900 0.52 4/20
SCHEMBL8489907 SCHEMBL8489907 0.52 4/20
SCHEMBL8492838 SCHEMBL8492838 0.52 4/20
SCHEMBL8492845 SCHEMBL8492845 0.52 4/20
SCHEMBL8489902 SCHEMBL8489902 0.51 4/20
SCHEMBL8489908 SCHEMBL8489908 0.51 4/20
SCHEMBL8491154 SCHEMBL8491154 0.51 4/20
SCHEMBL8491160 SCHEMBL8491160 0.51 4/20
SCHEMBL8491619 SCHEMBL8491619 0.50 4/20
SCHEMBL8491624 SCHEMBL8491624 0.50 4/20
SCHEMBL8491634 SCHEMBL8491634 0.50 4/20
7-Prenyloxycoumarin 7-Prenyloxycoumarin (SCHEMBL4898255) 0.79 3/20
SCHEMBL712741 SCHEMBL712741 0.57 3/20
Geiparvarin Geiparvarin (SCHEMBL2532495) 0.56 3/20
SCHEMBL6267768 SCHEMBL6267768 0.55 3/20
SCHEMBL8493191 SCHEMBL8493191 0.55 3/20
SCHEMBL8493327 SCHEMBL8493327 0.55 3/20

Clinical trials — most relevant to MT-ND2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease PHASE3COMPLETED
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) PHASE3WITHDRAWN
A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation PHASE3ACTIVE_NOT_RECRUITING
A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy PHASE2ACTIVE_NOT_RECRUITING
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder PHASE2WITHDRAWN
Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease PHASE2COMPLETED
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease PHASE2RECRUITING
Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)? PHASE1UNKNOWN
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine nanCOMPLETED
The Natural History of Mitochondrial Diseases nanRECRUITING
Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability. nanUNKNOWN
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases nanRECRUITING
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) nanRECRUITING
Survey on Supplement Use in Mitochondrial Disease nanCOMPLETED
Diagnostic Odyssey Survey 2 nanCOMPLETED
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Natural History in Primary Mitochondrial Myopathies nanRECRUITING
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
Calf Muscle Strength in Mitochondrial Diseases nanCOMPLETED
Red Light Ptosis Proof-of-Concept nanUNKNOWN
Mitoquines in COPD nanUNKNOWN
Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection nanCOMPLETED
Ccf mtDNA as a Neurodegenerative Biomarker nanUNKNOWN
Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy nanRECRUITING
Cardiac Mitochondrial Function in Explanted Human Hearts nanUNKNOWN
Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a MT-ND2 binder may also engage these)

ProteinNameSimilarity
Q95704 1.000 Q95704 →
O21798 1.000 O21798 →
Q34799 1.000 Q34799 →
Q9T9X8 1.000 Q9T9X8 →
Q9T9X1 1.000 Q9T9X1 →
Q9T9Y9 1.000 Q9T9Y9 →
P92691 1.000 P92691 →
Q330B3 0.998 Q330B3 →
O79671 0.997 O79671 →
Q36451 0.997 Q36451 →
Q330B1 0.997 Q330B1 →
Q330D8 0.997 Q330D8 →
Q2I3H3 0.996 Q2I3H3 →
P11662 0.996 P11662 →
Q85PQ7 0.996 Q85PQ7 →
Q8W9N5 0.995 Q8W9N5 →
Q32ZZ4 0.995 Q32ZZ4 →
Q71MY2 0.994 Q71MY2 →
Q330E9 0.994 Q330E9 →
Q85PS1 0.994 Q85PS1 →
Q8LX31 0.994 Q8LX31 →
P92660 0.994 P92660 →
Q330A5 0.994 Q330A5 →
Q330A8 0.994 Q330A8 →
Q330A0 0.994 Q330A0 →
Q330C4 0.993 Q330C4 →
O79428 0.993 O79428 →
Q330E5 0.993 Q330E5 →
Q94V92 0.993 Q94V92 →
Q330G8 0.993 Q330G8 →